They observed a significant downregulation of CCBE1 expression in tumors compared to non-tumor tissues, which was attributed to the high methylation of the CCBE1 promoter in HCC (Ga et al. 2023). This evidence concerns the gene CCBE1 and hepatocellular carcinoma.